SCBIO

Private

DaejeonHealthcare & Life Scienceshttp://sc-bio.co.kr/

Last Round

Series B

Sep 1, 2025

Total Funding Raised

$23.1M

Company Overview

SCBIO is a biotechnology company that discovers and develops novel small-molecule therapeutics with a focus on immuno-oncology and fibrosis treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug discoveryimmuno-oncologyantibody-drug conjugateADCpulmonary fibrosisbiotechsmall-molecule drugsorphan drugpreclinical testingtechnology licensingL/Obiopharmadrug pipelinepharmaceutical R&Dtherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SCBIO Comparables

Compare SCBIO with similar companies based on industry and business-model similarity.

SCBIO comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Avelos Therapeutics	85%
Nextgen Bioscience Co., Ltd.	82%
Wellmarker Bio	82%

View all Comparables

SCBIO Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Sep 1, 2025
Series A	May 18, 2023
Pre Seed	Aug 19, 2022

View all Funding Rounds

SCBIO Investors

Notable investors and investment history

SCBIO investors
Investor	Rounds
KOTEC	Pre Seed
Korea University Holdings	Pre Seed
A Ventures	Series A
SL Investment	Series B
iM Investment Partners	Series B
Xquared	Series B
TS Investment	Series A

View all Investors

SCBIO Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SCBIO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SCBIO's valuation, stock price, and market status.

Firmographic Details

HeadquartersDaejeon

Year Founded2021

Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?